Aadi Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for AADI, and what generic alternatives to AADI drugs are available?
AADI has one approved drug.
There are five US patents protecting AADI drugs.
There are one hundred and fourteen patent family members on AADI drugs in thirty-two countries and fourteen supplementary protection certificates in seven countries.
Summary for Aadi
| International Patents: | 114 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Aadi
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aadi | FYARRO | sirolimus | POWDER;INTRAVENOUS | 213312-001 | Nov 22, 2021 | RX | Yes | Yes | 10,973,806 | See Plans and Pricing | See Plans and Pricing | ||||
| Aadi | FYARRO | sirolimus | POWDER;INTRAVENOUS | 213312-001 | Nov 22, 2021 | RX | Yes | Yes | 10,705,070 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Aadi | FYARRO | sirolimus | POWDER;INTRAVENOUS | 213312-001 | Nov 22, 2021 | RX | Yes | Yes | 10,206,887 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Aadi | FYARRO | sirolimus | POWDER;INTRAVENOUS | 213312-001 | Nov 22, 2021 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| Aadi | FYARRO | sirolimus | POWDER;INTRAVENOUS | 213312-001 | Nov 22, 2021 | RX | Yes | Yes | 8,911,786 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Aadi | FYARRO | sirolimus | POWDER;INTRAVENOUS | 213312-001 | Nov 22, 2021 | RX | Yes | Yes | 11,497,737 | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Aadi Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Argentina | 120318 | See Plans and Pricing |
| Russian Federation | 2011146132 | See Plans and Pricing |
| South Korea | 20170014007 | See Plans and Pricing |
| Japan | 2010520289 | See Plans and Pricing |
| Japan | 6433371 | See Plans and Pricing |
| Israel | 215765 | See Plans and Pricing |
| Australia | 2020375810 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Aadi Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0648494 | 24/2001 | Austria | See Plans and Pricing | PRODUCT NAME: SIROLIMUS; NAT. REGISTRATION NO/DATE: EU/1/01/171/001 - EU/1/01/171/005 20010313; FIRST REGISTRATION: LI 5524301 20000926 |
| 0401747 | SPC/GB01/036 | United Kingdom | See Plans and Pricing | PRODUCT NAME: SIROLIMUS; REGISTERED: CH IKS 55243 20000926; UK EU/1/01/171/001-005 20010313 |
| 0763039 | PA2008009 | Lithuania | See Plans and Pricing | PRODUCT NAME: TEMSIROLIMUSUM; REG. NO/DATE: EU/1/07/424/001 20071119 |
| 0401747 | 25/2001 | Austria | See Plans and Pricing | PRODUCT NAME: SIROLIMUS; NAT. REGISTRATION NO/DATE: EU/1/01/171/001 - EU/1/01/171/005 20010313; FIRST REGISTRATION: LI 5524301 20000926 |
| 0763039 | C300348 | Netherlands | See Plans and Pricing | PRODUCT NAME: TEMSIROLIMUS, DESGEWENST IN DE VORM VAN EEN; REGISTRATION NO/DATE: EU/1/07/424/001 20071119 |
| 0763039 | SPC/GB08/025 | United Kingdom | See Plans and Pricing | PRODUCT NAME: TEMSIROLIMUS AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/07/424/001 20071119 |
| 0648494 | SPC/GB01/037 | United Kingdom | See Plans and Pricing | PRODUCT NAME: SIROLIMUS; REGISTERED: CH IKS 55243 20000926; UK EU/1/01/171/001-005 20010313 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
